J
Judit Boda-Heggemann
Researcher at Heidelberg University
Publications - 115
Citations - 2408
Judit Boda-Heggemann is an academic researcher from Heidelberg University. The author has contributed to research in topics: Radiation therapy & Medicine. The author has an hindex of 24, co-authored 97 publications receiving 1910 citations.
Papers
More filters
Journal ArticleDOI
Deep Inspiration Breath Hold-Based Radiation Therapy : A Clinical Review
Judit Boda-Heggemann,Antje-Christin Knopf,Anna Simeonova-Chergou,Hansjörg Wertz,Florian Stieler,Anika Jahnke,L. Jahnke,Jens Fleckenstein,Lena Vogel,A. Arns,Manuel Blessing,Frederik Wenz,Frank Lohr +12 more
TL;DR: This review provides an in-depth discussion of the rationale and technical implementation of DIBH gating for hypofractionated and norm ofractionated RT of intrathoracic and upper abdominal tumors in photon and proton RT.
Journal ArticleDOI
kV cone-beam CT-based IGRT: a clinical review.
TL;DR: In this paper, an overview on the clinical applications of kilovoltage gantry-mounted CBCT systems with emphasis on the most frequently targeted body sites (prostate, lung, head and neck) is provided based on a review of the relevant literature.
Journal ArticleDOI
Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
Juliane Rieber,Jan Streblow,Lorenz Uhlmann,Michael Flentje,Marciana Nona Duma,Iris Ernst,Oliver Blanck,Andrea Wittig,Judit Boda-Heggemann,Robert Krempien,Fabian Lohaus,N. D. Klass,Michael J. Eble,Detlef Imhoff,H. Kahl,Cordula Petersen,Sabine Gerum,Christoph Henkenberens,Sonja Adebahr,Peter Hass,E. Schrade,Thomas G. Wendt,Guido Hildebrandt,Nicolaus Andratschke,Florian Sterzing,Matthias Guckenberger,Matthias Guckenberger +26 more
TL;DR: SBRT for medically inoperable patients with pulmonary metastases achieved excellent local control and promising overall survival and important prognostic factors were identified for selecting patients who might benefit most from this therapy approach.
Journal ArticleDOI
Phantom and in-vivo measurements of dose exposure by image-guided radiotherapy (IGRT) : MV portal images vs. kV portal images vs. cone-beam CT
Cornelia Walter,Judit Boda-Heggemann,Hansjörg Wertz,Iris Loeb,A.N. Rahn,Frank Lohr,Frederik Wenz +6 more
TL;DR: CBCT provides a 3D-image dataset and dose exposure for one scan is lower than for two MV PI, thus rendering frequent volume imaging during a fractionated course of radiotherapy possible, and even taking into account an RBE, for kV PI the delivered dose is lower and image quality is better than for MV PI.
Journal ArticleDOI
The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases
N. Andratschke,H. Alheid,Michael Allgäuer,Gerhild Becker,Oliver Blanck,Judit Boda-Heggemann,Thomas B. Brunner,Marciana-Nona Duma,Sabine Gerum,Matthias Guckenberger,Guido Hildebrandt,Rainer J. Klement,V. Lewitzki,C. Ostheimer,Alexandros Papachristofilou,Cordula Petersen,Thomas Schneider,Robert Semrau,Stefan Wachter,Daniel Habermehl +19 more
TL;DR: After an initial learning curve with regards to total cumulative doses, consistently high biologically effective doses have been employed translating into high local tumor control at 1 and 2 years and overall survival is mainly influenced by histology and metastatic tumor burden.